Reduction in inappropriate therapy and mortality through ICD programming

New England Journal of Medicine

Volumn 367, Issue 24, 2012, Pages 2275-2283

  Moss, Arthur J ^a   Schuger, Claudio ^b   Beck, Christopher A ^a   Brown, Mary W ^a   Cannom, David S ^c   Daubert, James P ^d   Estes III, N A Mark ^e   Greenberg, Henry ^f   Hall, W Jackson ^a   Huang, David T ^a   Kautzner, Josef ^g   Klein, Helmut ^a   McNitt, Scott ^a   Olshansky, Brian ^h   Shoda, Morio ⁱ   Wilber, David ^j   Zareba, Wojciech ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c GOOD SAMARITAN HOSPITAL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^h UNIVERSITY OF IOWA HEALTH CARE   (United States)

ⁱ TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^j LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; CARDIOGENIC SHOCK; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEVICE SAFETY; DEVICE THERAPY; FEMALE; FOLLOW UP; HEALTH CARE CONCEPTS; HEART RATE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INAPPROPRIATE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; THERAPY DELAY; THERAPY EFFECT; TREATMENT INDICATION;

EID: 84871065661     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1211107     Document Type: Article

References (22)

1. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
2. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
3. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. [Erratum, N Engl J Med 2005;352:2146.]
4. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
5. Daubert JP, Zareba W, Cannom DS, et al. Inappropriate implantable cardioverterdefibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008;51:1357-65.
6. van Rees JB, Borleffs CJ, de Bie MK, et al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011;57:556-62.
7. Saeed M, Razavi M, Neason CG, Petrutiu S. Rationale and design for programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock (PROVIDE) study. Europace 2011;13:1648-52.
8. Schuger C, Daubert JP, Brown MW, et al. Multicenter Automatic Defibrillator Implantation Trial: Reduce Inappropriate Therapy (MADIT-RIT): background, rationale, and clinical protocol. Ann Noninvasive Electrocardiol 2012;17:176-85.
9. Healy B, Campeau L, Gray R, et al. Conflict-of-interest guidelines for a multicenter clinical trial of treatment after coronary-artery bypass-graft surgery. N Engl J Med 1989;320:949-51.
10. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008;117(21):e350-e408. [Erratum, Circulation 2009;120(5):e34-e35.]
11. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982;65:457-64.
12. Cox DR. Regression models and lifetables. J R Stat Soc [B] 1972;34:187-220.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
14. Wilkoff BL, Williamson BD, Stern RS, et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52:541-50.
15. Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004;110:2591-6.
16. Goldenberg I, Moss AJ, Hall WJ, et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2006;113:2810-7.
17. Barker-Voelz MA, Van Vleet JF, Tacker WA Jr, Bourland JD, Geddes LA, Schollmeyer MP. Alterations induced by a single defibrillating shock applied through a chronically implanted catheter electrode. J Electrocardiol 1983;16:167-79.
18. Epstein AE, Kay GN, Plumb VJ, Dailey SM, Anderson PG. Gross and microscopic pathological changes associated with nonthoracotomy implantable defibrillator leads. Circulation 1998;98:1517-24.
19. Tereshchenko LG, Faddis MN, Fetics BJ, Zelik KE, Efimov IR, Berger RD. Transient local injury current in right ventricular electrogram after implantable cardioverter-defibrillator shock predicts heart failure progression. J Am Coll Cardiol 2009;54:822-8.
20. Xie J, Weil MH, Sun S, et al. Highenergy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation 1997;96:683-8.
21. Pacifico A, Hohnloser SH, Williams JH, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol N Engl J Med 1999;340:1855-62.
22. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.